interventional
N/A
1 country
1
To evaluate the efficacy of Escherichia coli Nissle 1917 (ECN) in patients with autoimmune uveitis
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
Not reported
Date not reportedClick on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
October 11, 2024
Actual (reported)Time to first disease relapse from the baseline visit (V2)
Severity of first relapse according to the SUN system
Total number of relapses during the study
Changes in BCVA
Changes in OCT parameters
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
Contact the study team to confirm eligibility.
Vseobecna Fakultni Nemocnice V Praze
Prague, 128 00, Czechia
Mgr. Martina Racková, MBA
First Submitted
October 11, 2024
Download the complete CTIS (EMA) record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: European Medicines Agency (EMA), Clinical Trials Information System (CTIS). Original record and public documents are available on CTIS.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: